Physician profile
Sameer Alrefai
NPI 1205141819
$23,411.66
in general payments reported to CMS, 2019-2025
15 companies · $2,158 in 2025
The $2,158 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $8,557 · 2023: $6,510 · 2024: $6,187 · 2025: $2,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,322 · Food and Beverage: $6,388 · Education: $1,000 · Gift: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,322.22 |
| Food and Beverage | $6,388.18 |
| Education | $1,000.00 |
| Gift | $144.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,144.16 | 2022-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $7,105.33 | 2023-2025 | Seamguard, Gore Bio-A Tissue Reinforcement, Gore Tag Thoracic Endoprosthesis |
| Davol INC. | $784.21 | 2025 | Phasix Mesh |
| Tela Bio, INC. | $73.70 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $52.20 | 2023 | Skyrizi |
| Novo Nordisk INC | $48.33 | 2024-2025 | Wegovy |
| Medtronic, INC. | $42.74 | 2025 | Progrip |
| Boston Scientific Corporation | $28.67 | 2023 | Varithena Administration Pack |
| Acera Surgical, INC. | $27.67 | 2024 | Restrata Wound Matrix |
| Intra-Sana Laboratories | $22.97 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Lilly USA, LLC | $18.38 | 2024 | Zepbound |
| Convatec INC. | $18.07 | 2025 | |
| Kci USA, INC. | $16.89 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Dermatac |
| Ethicon US, LLC | $15.26 | 2022 | |
| Smith+Nephew, INC. | $13.08 | 2024 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Alrefai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.